Diagnosis and management of nonalcoholic fatty liver disease
Paul S, Davis AM
JAMA. Published online, 26 November 2018.
Leggi
Breaking news
Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study
Patterson CC, Harjutsalo V, Rosenbauer J, et al.
Diabetologia. Published online, 28 November 2018.
Leggi
Healthcare providers’ advice on lifestyle modification in the us population: results from the national health and nutrition examination survey 2011-2016
Grabovac I, Smith L, Stefanac S, et al.
The American Journal of Medicine. Published online, 3 December 2018.
Leggi
Psoriasis: a novel risk factor for type 2 diabetes
Gelfand JM, Wan MT
Lancet Diabetes Endocrinol. 2018;6(12):919-21
Leggi
Serum insulin and cognitive performance in older adults: a longitudinal study
Hooshmand B, Rusanen M, Ngandu T, et al.
The American Journal of Medicine. Published online, 29 November 2018
Leggi
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial
de Zeeuw D, Renfurm RW, Bakris G, et al.
Lancet Diabetes Endocrinol. 2018;6(12):925-33
Leggi
Emerging paradigms of treating diabetic nephropathy
Chang Y, Moradi H, Kalantar-Zadeh K
Lancet Diabetes Endocrinol. 2018;6(12):912-3
Leggi
Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus
Colunga-Lozano LE1, Gonzalez Torres FJ, Delgado-Figueroa N, et al.
Cochrane Database Syst Rev. 2018;11:CD011296.
Leggi
Diabetes care for patients experiencing homelessness: beyond metformin and sulfonylureas
Brooks LK, Kalyanaraman N, Malek R
The American Journal of Medicine. Published online, 22 November 2018
Leggi
Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis
Basu S, Yudkin JS, Kehlenbrink S
The Lancet Diabetes and Endocrinology. Published Online, 20 November, 2018
Leggi